Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMNW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $160,743
Award facts
- Contract value 100% obligated
- $160,742.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $160,742.53 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a single award with no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will supply a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a major $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. As a single-award prime vendor contractor with no identified subcontractors, DMS Pharmaceutical Group has demonstrated substantial performance through numerous prior delivery orders and maintains critical supply chain responsibilities for the Department of Defense's pharmaceutical and medical consumables requirements globally.
Quick answers
Who was awarded contract SPE2DU26FEMNW?
SPE2DU26FEMNW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DU26FEMNW worth?
The government has obligated $160,743 on SPE2DU26FEMNW.
Is contract SPE2DU26FEMNW an order under another contract?
Yes. SPE2DU26FEMNW is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNW competed?
The extent of competition for SPE2DU26FEMNW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award